...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of drug assessment >Improvement of headache symptoms and reduction in headache medication usage in patients treated with botulinum toxin type A
【24h】

Improvement of headache symptoms and reduction in headache medication usage in patients treated with botulinum toxin type A

机译：用A型肉毒毒素治疗的患者改善头痛症状并减少头痛药物的使用

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The charts of 132 consecutive patients receiving botulinum toxin type A (BoNT-A; BOTOX~R) for headache prevention were reviewed retrospectively. During a follow-up visit, patients reported their overall improvement in headache symptoms. Headache medication utilisation and costs for the 6 months before and during treatment were compared using the Average Wholesale Price. The mean BoNT-A dose used was 101.9 units and 131/132 patients (99%) reported some improvement in headache symptoms. Patients reported an average of 77% improvement in their headache symptoms from baseline. BoNT-A treatment resulted in a 47.2% reduction in the use of headache medications. The average monthly cost of all oral headache medications declined from
机译：回顾性分析了132例连续接受A型肉毒杆菌毒素（BoNT-A; BOTOX〜R）预防头痛的患者的病历。在随访期间，患者报告了头痛症状的总体改善。使用平均批发价比较治疗前和治疗中6个月的头痛药物利用率和成本。使用的BoNT-A平均剂量为101.9单位，有131/132例患者（99％）报告头痛症状有所改善。患者报告其头痛症状平均较基线改善了77％。 BoNT-A治疗使头痛药物的使用减少了47.2％。所有口服头痛药物的平均每月费用从

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号